Chronic obstructive pulmonary disease and arterial hypertension: methaphysics and dialectic
- Authors: Li V.V1, Zadionchenko V.S1, Adasheva T.V1, Pavlov S.V1, Shakhrai N.B1
-
Affiliations:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation
- Issue: Vol 4, No 1 (2013)
- Pages: 5-10
- Section: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/44977
- DOI: https://doi.org/10.26442/CS44977
- ID: 44977
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V. V Li
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation
Email: vera0212@yandex.ru
Department of Therapy and Family Medicine
V. S Zadionchenko
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian FederationDepartment of Therapy and Family Medicine
T. V Adasheva
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian FederationDepartment of Therapy and Family Medicine
S. V Pavlov
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian FederationDepartment of Therapy and Family Medicine
N. B Shakhrai
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian FederationDepartment of Therapy and Family Medicine
References
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised 2011). www.goldcopd.com
- Fabbri L.M., Luppi F, Beghe B, Rabe K.F. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31: 204–12.
- Kriegsman D.M., Deeg D.J., Stalman W.A. Comorbidity of somatic chronic diseases and decline in physical functioning: the Longitudinal Aging Study Amsterdam. J Clin Epidemiol 2004; 57: 55–65.
- McGarvey L.P., John M, Anderson J.A. et al. Ascertainment of cause - specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411–5.
- Anthonisen N.R., Connett J.E., Enright P.L. et al. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333–9.
- Holguin F, Folch E, Redd S.C. et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128: 2005–11.
- Sidney S, Sorel M, Quesenberry C.P. et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068–75.
- Selvaraj C.L., Gurm H.S., Gupta R. et al. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2005; 96: 756–9.
- Han M.K., Agusti A, Calverley P.M. et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182 (5): 598–604.
- Авдеев C.Н. Фенотипы хронической обструктивной болезни легких: особенности терапии. Пульмонология. Cons. Med. 2010; с. 3–29.
- Burgel P.R., Paillasseur J.L., Caillaud D et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36: 531–9.
- Enriquez J.R., Parikh S.V., Selzer F. et al. Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Chest 2011; 1403: 604–10.
- Paul Man S.F., Leipsic J.A., Man J.P., Sin D.D. Is Atherosclerotic Heart Disease in COPD a Distinct Phenotype. Chest 2011; 40 (3): 569–71.
- Мухарлямов Н.М., Саттбеков Ж.С., Сучков В.В. Системная артериальная гипертензия у больных хроническими неспецифическими заболеваниями легких. Кардиология. 1974; 12 (34): 55–61.
- Ольбинская Л.И., Белов А.А., Опаленов Ф.В. Суточный профиль артериального давления при хронических обструктивных заболеваниях легких и при их сочетании с артериальной гипертензией. Рос. кардиол. журн. 2000; 2: 20–5.
- Echave J.M., Martin-Escudero J.C., Anton E. et al. Comorbidity in COPD in Spain. Am J Respir Crit Care Med 2009; 179: A1462.
- Boutin-Forzano S, Moreau D, Kalaboka S et al. Reported prevalence and comorbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation. Int J Tuberc Lung Dis 2007; 11: 695–702.
- Mannino D.M., Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32 (4): 962–9.
- Сrisafulli E, Gorgone P, Vagaggini B et al. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J 2010; 36: 1042–8.
- Nussbaumer-Ochsner Y, Rabe K.F. Systemic Manifestations of COPD Chest 2011;139 (1): 165–73.
- Cachofeiro V, Miana M et al. Inflammation: A Link Between Hypertension and Atherosclerosis. Current Hypertension Reviews 2009; 5 (1): 40–8.
- Gordon C, Gudi K, Krause A et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011; 184: 224–32.
![](/img/style/loading.gif)